Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Traci Nauser

Obstetrics Overland Park, KS Medical Doctor

NPI 1790754349 CMS profile 125968

4840 College Blvd, Overland Park, KS 66211

Open in the dashboard

General payments

$4,609

283 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Traci Nauser of Overland Park, KS is reported in the CMS Open Payments database as having received $4,609 across 283 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Obstetrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $545 33
2024 General $438 29
2023 General $731 37
2022 General $728 51
2021 General $995 52
2020 General $782 52
2019 General $390 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Traci Nauser
  • Obstetrics median
  • Middle half of Obstetrics
  • National median

In program year 2025, general payments to Traci Nauser were reported at $545. Among 649 Obstetrics profiles paid that year, the median was $181 and the middle half received between $61 and $424.

Show as a table
Year Traci Nauser Obstetrics median Middle half National median
2019 $390 $177 $60–$381 $163
2020 $782 $92 $35–$201 $114
2021 $995 $125 $40–$351 $132
2022 $728 $186 $65–$448 $149
2023 $731 $183 $61–$451 $160
2024 $438 $176 $62–$406 $164
2025 $545 $181 $61–$424 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $1,202 68 payments
  2. Mayne Pharma Inc. $685 53 payments
  3. Avion Pharmaceuticals $570 57 payments
  4. Daiichi Sankyo Inc. $220 7 payments
  5. Exeltis, USA Inc. $198 12 payments
  6. Astellas Pharma US Inc $185 4 payments
  7. Allergan Inc. $182 17 payments
  8. Agile Therapeutics, Inc. $149 8 payments
  9. CooperSurgical, Inc. $130 3 payments
  10. Novo Nordisk Inc $102 1 payment
  11. Other $987 53 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,596 282 payments
  2. Education $13 1 payment
Products named General payments · program years 2019–2025
  1. LO LOESTRIN FE $691 45 payments
  2. ORILISSA $529 20 payments
  3. ORIAHNN $413 16 payments
  4. Balcoltra Oral contraceptive $332 36 payments
  5. Balcoltra Oral contraceptive $199 19 payments
  6. INJECTAFER $187 5 payments
  7. Veozah $185 4 payments
  8. LILETTA $152 11 payments
  9. Twirla $149 8 payments
  10. ANNOVERA $117 1 payment
  11. Other $2,163 117 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

42

Median for Obstetrics & Gynecology: 65

Drug cost

$2,482

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

52.4%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 20 $1,476
Dotti Estradiol Brand 11 $646
Valacyclovir Valacyclovir Hcl Brand 11 $360

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 30 billing codes

Paid by Medicare

$9,006

Medicare's payments for the services billed

Medicare patients

67

Average age 69

Services billed

171

67 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 45%
Arthritis 40%
Depression 22%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Veozah
  • Astellas Pharma US Inc $21
$21 — —
SLYND
  • Exeltis, USA Inc. $17
$17 — —
LO LOESTRIN FE
  • AbbVie, Inc. $15
$15 — —
ORILISSA
  • AbbVie, Inc. $15
$15 — —
CONTRAVE
  • Currax Pharmaceuticals LLC $13
$13 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

283 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record